Form 13-F position report

UNITEDHEALTH GROUP INC

Reported by Pegasus Partners Ltd

UNH CUSIP 91324P102 Manager CIK 0001650654

Reported 11,647 shares, down 792 (6.4%) from the prior quarter.

Reported value 20.3%; share count -6.4% vs. the prior quarter.

Reduced
% of reported 13F value 1.02% This manager · Q4 2021
Shares 11,647 Quarter-end amount reported
Reported value $5,848,000 Fair value at quarter end
Consecutive quarters held 27 Through Q4 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2019-12-31 4781000
2020-03-31 4025000
2020-06-30 5184000
2020-09-30 5252000
2020-12-31 5975000
2021-03-31 5367000
2021-06-30 5220000
2021-09-30 4860000
2021-12-31 5848000
2022-03-31 5598000
2022-06-30 5649000
2022-09-30 5792000
2022-12-31 6333530
2023-03-31 5501893
2023-06-30 5550431
2023-09-30 6127422
2023-12-31 6039664
2024-03-31 5671241
2024-06-30 4653109
2024-09-30 4935869

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for UNITEDHEALTH GROUP INC held by Pegasus Partners Ltd.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2024 Reduced 8,442 -695 (-7.6%) 0.46% $4,935,869 2024-11-01
Q2 2024 Reduced 9,137 -2,327 (-20.3%) 0.47% $4,653,109 2024-08-08
Q1 2024 Reduced 11,464 -8 (-0.1%) 0.6% $5,671,241 2024-04-24
Q4 2023 Reduced 11,472 -681 (-5.6%) 0.71% $6,039,664 2024-02-12
Q3 2023 Added 12,153 +605 (5.2%) 0.86% $6,127,422 2023-11-13
Q2 2023 Reduced 11,548 -94 (-0.8%) 0.82% $5,550,431 2023-08-04
Q1 2023 Reduced 11,642 -304 (-2.5%) 0.87% $5,501,893 2023-05-10
Q4 2022 Added 11,946 +477 (4.2%) 1.04% $6,333,530 2023-02-09
Q3 2022 Added 11,469 +471 (4.3%) 1.19% $5,792,000 2022-11-10
Q2 2022 Added 10,998 +20 (0.2%) 1.18% $5,649,000 2022-08-12
Q1 2022 Reduced 10,978 -669 (-5.7%) 0.98% $5,598,000 2022-05-13
Q4 2021 Reduced 11,647 -792 (-6.4%) 1.02% $5,848,000 2022-02-09
Q3 2021 Reduced 12,439 -596 (-4.6%) 0.88% $4,860,000 2021-11-12
Q2 2021 Reduced 13,035 -1,391 (-9.6%) 1.02% $5,220,000 2021-08-13
Q1 2021 Reduced 14,426 -2,612 (-15.3%) 1.18% $5,367,000 2021-05-14
Q4 2020 Added 17,038 +191 (1.1%) 1.51% $5,975,000 2021-02-12
Q3 2020 Reduced 16,847 -730 (-4.2%) 1.59% $5,252,000 2020-11-13
Q2 2020 Added 17,577 +1,436 (8.9%) 1.68% $5,184,000 2020-08-12
Q1 2020 Reduced 16,141 -122 (-0.8%) 1.58% $4,025,000 2020-05-11
Q4 2019 Added 16,263 +548 (3.5%) 1.46% $4,781,000 2020-02-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

2878 managers reported UNITEDHEALTH GROUP INC for Q4 2021.

Managers reporting UNITEDHEALTH GROUP INC in Q4 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 79,483,862 +315,811 0.91% $39,912,025,000 35 qtrs
BlackRock Inc Reduced 69,259,425 -447,120 0.89% $34,777,929,000 35 qtrs
FMR LLC Reduced 48,023,932 -75,338 1.78% $24,114,737,000 35 qtrs
STATE STREET CORPORATION Added 45,559,868 +869,827 1.08% $22,877,432,000 35 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 34,428,521 -827,374 1.56% $17,287,937,000 35 qtrs
Capital World Investors Reduced 33,870,309 -398,100 2.69% $17,007,716,000 35 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 29,036,147 -980,289 2.33% $14,580,210,000 35 qtrs
Capital International Investors Added 19,342,468 +790,219 2.05% $9,713,058,000 20 qtrs
Capital Research Global Investors Reduced 17,791,353 -234,019 1.97% $8,933,774,000 35 qtrs
JPMorgan Chase & Co Added 15,815,496 +748,575 0.92% $7,941,593,000 35 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2021
Filed
February 09, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
11,647
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.